Alma Launches Alma HybridTM, the First and Only Device of Its Kind

Alma, a Sisram Medical Company, Launches Alma HybridTM, the First and Only Device of Its Kind – Exclusively Combining 3 Powerful Energy Sources to Deliver Unparalleled Results

Alma HybridOctober 22nd, 2020, Nurnberg, Germany – Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, unveiled its new Alma HybridTM platform today, during a worldwide LIVE launch event, which was broadcasted from a state-of-the-art studio that was built especially at Alma’s headquarters for this event.
Designed to enable endless options of ablative, non-ablative and thermal treatments for skin rejuvenation and scar revision, Alma HybridTM creates a unique synergistic effect by combining the power of three core energies, including:
• CO2 laser – an optimal blend of ablative, coagulative and thermal effects for efficient, highly precise focused or fractional laser treatments.
• 1570nm laser – a powerful non-ablative modulated fiber laser, which creates a thermal effect that promotes new dermis synthesis while leaving the epidermis intact.
• IMPACT for Trans Epidermal Delivery (TED) – Alma’s patented Ultrasound technology, which uses acoustic pressure to deliver pharmaceuticals and cosmeceuticals trans-epidermally to achieve enhanced results.
At the heart of the Alma HybridTM platform is HyGridTM, Alma’s novel hybrid applicator, which facilitates a customized skin-program matrix for any desired combination of ablation vs. non ablation ratio within the treated area. HyGridTM enables practitioners to meet each and every patient’s specific treatment needs, as well as the desired balance between results timeline and patient’s downtime.
In addition to this powerful combination of tools, Alma HybridTM smart software serves as a key solution component, which enables practitioners to craft “signature treatments” that bring their unique skills and experience into action.
“The revolutionary HyGridTM mode allows me to customize the optimal ratio between CO2 and non-ablative treatments and to maximize the effect of each laser wavelength. I find this to be a substantial step forward in terms of the personalization of laser treatments for various skin conditions,” said Dr. Ofir Artzi, Chairman of SCARS, the international scar treatment conference.
“We are extremely proud to deliver the magic “behind the scenes” that enables top practitioners to bring their skills and experience to light,” said Lior Dayan, CEO of Alma. “This is a milestone for us as a company, as well as for all medical professionals who will be using it, and for the patients who will enjoy its remarkable results.”